RecruitingNot applicableNCT05651113

The Experience of Screening for SCID

Studying Severe combined immunodeficiency

Last synced from ClinicalTrials.gov May 1, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: King's College London
Intervention: SCID Screening(other)
Enrollment: 90 enrolled
Eligibility: 18 years · All sexes
Timeline: 2022 – 2029

Study locations (1)

King's College London, London, United Kingdom

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05651113 on ClinicalTrials.gov

Other trials for Severe combined immunodeficiency

Additional recruiting or active studies for the same condition.

ENROLLING BY INVITATIONPHASE1, PHASE2NCT01852370
Sequential Cadaveric Lung and Bone Marrow Transplant for Immune Deficiency Diseases
Paul Szabolcs
ENROLLING BY INVITATIONNCT01186913
Natural History Study of SCID Disorders
National Institute of Allergy and Infectious Diseases (NIAID)

See all trials for Severe combined immunodeficiency →

← Back to all trials